Get instant access to pre-configured Clinical Outcome Assessments (COAs) available from Oxford University Innovation (OUI) through IQVIA’s eCOA platform

16th April 2021

OUI’s portfolio of COAs now ready for immediate electronic deployment, following rigorous review and testing, straight out of IQVIA’s eCOA library.

Minimizing the time required to properly deploy COA instruments within an eCOA study system is a key benefit for clinical trials. This process has traditionally taken months, or even years, to ensure instrument developers (and sponsors) are confident in the faithful reproduction of their instrument. This collaboration allows for OUI’s portfolio of COAs to be ready for immediate electronic deployment, following rigorous review and testing, straight out of IQVIA’s eCOA library.

Within the OUI portfolio, instruments that are regularly used by trial sponsors, include the Parkinson’s Disease Questionnaire (PDQ), the Endometriosis Health Profile (EHP), the Amyotrophic Lateral Sclerosis Questionnaire (ALSAQ), the Recovering Quality of Life Questionnaire (ReQoL) and the Oxford Participation and Activities Questionnaire (OxPAQ), some of which are viewed as industry gold-standard instruments and are widely used. All these have proven measurement properties to effectively capture how a patient is feeling or functioning with a certain disease or condition, and thereby capture the patient’s voice.

The IQVIA electronic Clinical Outcome Assessment (eCOA) solution is an advanced study build and execution platform that optimizes real-time, direct-from-patient data collection in clinical research and real-world studies. The simple, intuitive interface enhances the patient experience while improving data quality. IQVIA eCOA is designed to amplify the patient voice, accelerate outcomes, and enable sponsors to achieve study goals with confidence.

For all enquiries, including licensing of our COA’s please email healthoutcomes@innovation.ox.ac.uk.

The Clinical Outcomes Team.

Press release sign up